CLINICAL_TRIALS
research
· 2025-05-02
Clinical Trial Update: Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Summary
Imperial College London is conducting a study to evaluate volatile organic compounds in breath as biomarkers for esophageal cancers. The trial is currently recr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Imperial College London | Conditions: Oesophageal Squamous Cell Carcinoma, Oesophageal Cancer | Status: RECRUITING